Latest featured videos from SpringfieldNewsSun.com
Xyzal Approved for Younger Kids

Xyzal Approved for Younger Kids

Related News from HealthDay
[an error occurred while processing this directive]
   

TUESDAY, Aug. 25 (HealthDay News) -- The antihistamine Xyzal (levocetirizine dihydrochloride) has been approved for children aged six months and older for indoor allergies and hives, drug makers UCB and Sanofi-Aventis said.

The medication, available as a liquid or pill, had been approved previously for people aged six years and older. The expanded approval also sanctions the drug's use to treat outdoor allergies in children aged two years and older.

Side effects of the medication may include fatigue, sore throat and dry mouth. Younger children may have additional adverse effects including fever, diarrhea, vomiting, ear infections and constipation, the drug makers said in a news release.

More information

The FDA has more information about this drug's approval history.

 

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Home | News | Sports | Entertainment | Opinion | Life | Recreation | Photos & Video | Jobs | Cars | Homes
Advertising Media Kit | Online Ad Studio | Advertiser Tools | Customer Service | Our Partners | RSS | Site Map

Copyright © 2010 Cox Ohio Publishing, Dayton, Ohio, USA. All rights reserved.

By using this site, you accept the terms of our Visitors Agreement and Privacy Policy. You may wish to note our other business policies.

This website is ACAP-enabled